Skip to main content

Main menu

Home
Current Issue
Archive
Info for
Other Publications
More
About Us
- General Policy
- Contact

Other Publications

User menu

Register
Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

Other Publications

Register
Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Current Issue
Archive
Info for
Other Publications
More
About Us
- General Policy
- Contact

Visit us on Facebook
Follow us on Linkedin

Archive of all online content

January 01, 2004 - May 01, 2021

Show Covers?

Browse by Volumes

2000s
2010s
2020s

2004
2005
2006
2007
2008
2009

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019

2020
2021

2008

November

November-December 2008; 28 (6B) + Index
November-December 2008 : Vol. 28, Issue 6B: 3835-4294
November-December 2008 : Vol. 28, Issue 6A: 3557-3833

September

September-October 2008 : Vol. 28, Issue 5C: 3157-3556
September-October 2008 : Vol. 28, Issue 5B: 2843-3155
September-October 2008 : Vol. 28, Issue 5A: 2529-2841

July

July-August 2008 : Vol. 28, Issue 4C: 2279-2527
July-August 2008 : Vol. 28, Issue 4B: 2019-2277
Special Issue on Prostate Cancer Research in Taiwan
July-August 2008 : Vol. 28, Issue 4A: 1969-2041

May

May-June 2008 : Vol. 28, Issue 3B: 1725-1965
May-June 2008 : Vol. 28, Issue 3A: 1441-1724

March

March-April 2008 : Vol. 28, Issue 2B: 1133-1439
March-April 2008 : Vol. 28, Issue 2A: 571-1132

January

January-February 2008 : Vol. 28, Issue 1B: 353-569
January-February 2008 : Vol. 28, Issue 1A: 1-352

Current Issue

May 2021 (Vol. 41 Issue 5) Table of Contents

Anticancer Research: 41 (5)

Issue highlights

IL-39 Reduces Proliferation and Promotes Apoptosis of Bladder Cancer by Altering the Activity of Cyclin E and Fas
Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening
Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation
What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Known, Diffuse Metastatic Disease to Bone?
Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma

Navigate To

Volume *

Issue

© 2021 Anticancer Research